Veradigm Inc. (MDRX)
OTCMKTS · Delayed Price · Currency is USD
4.920
+0.120 (2.50%)
Nov 12, 2025, 4:00 PM EST
Veradigm Market Cap
Veradigm has a market cap or net worth of $836.2 million as of November 12, 2025. Its market cap has decreased by -45.50% in one year.
Market Cap
836.20M
Enterprise Value
609.05M
Revenue
588.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.92
Market Cap Chart
Since October 13, 2008, Veradigm's market cap has increased from 311.82M to 836.20M, an increase of 168.17%. That is a compound annual growth rate of 5.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 836.20M | -49.42% |
| Dec 31, 2024 | 1.65B | 44.24% |
| Dec 29, 2023 | 1.15B | -40.53% |
| Dec 30, 2022 | 1.93B | -14.77% |
| Dec 31, 2021 | 2.26B | -0.87% |
| Dec 31, 2020 | 2.28B | 43.15% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 679.77M |
| Glass House Brands | 625.26M |
| Northwest Biotherapeutics | 381.28M |
| American Oncology Network | 326.01M |
| CytoDyn | 314.31M |
| Nika Pharmaceuticals | 311.89M |
| Silence Therapeutics | 299.94M |
| Global Cord Blood | 147.31M |